Reporter brief
RCT of rapamycin on muscle in older men: effects alone and with resistance exercise.
What happened
This is a planned RCT that aimed to recruit 16 healthy men over 50 years old to investigate how rapamycin (a mTOR inhibitor) affects muscle mass and function, both as monotherapy and combined with resistance exercise training. The source provided only the study rationale and design intent, with no outcome data reported.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Healthy male volunteers over 50 years old
- Design
- Rct
- Sample
- 16
- Journal
- University of Nottingham
- Published
- Apr 10, 2025
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Rapamycin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.